Submitted by Luthien Cangemi on Mon, 21/10/2024 - 11:38
Cambridge has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK government’s new research funding agency to work across life sciences, technology and business worlds to fast-track radical new technologies to revolutionise brain health. Congratulations to all the partners involved in this new and exiting project, and especially to one of the project leaders, and CIND-member, Professor George Malliaras from the University of Cambridge’s Department of Engineering, whose hopeful comments offer insights into a better future for brain heath: “Miniaturised devices have the potential to change the lives of millions of people currently suffering from neurological conditions and diseases where drugs have no effect,” he said. “But we are working at the very edge of what is possible in medicine, and it is hard to find the support and funding to try radical, new things. That is why the partnership with ARIA is so exhilarating, because it is giving brilliant people the tools to turn their original ideas into commercially viable devices that are cheap enough to have a global impact.”
The Cambridge partners are as follows:
Department of Engineering, University of Cambridge
Department of Psychiatry, University of Cambridge
The Milner Therapeutics Institute
Cambridge University Health Partners (CUHP)
Cambridgeshire and Peterborough NHS Foundation Trust
Created by an Act of Parliament, and sponsored by the Department for Science, Innovation, and Technology, ARIA IS is an R&D funding agency created to unlock technological breakthroughs that benefit everyone, which fund projects across the full spectrum of R&D disciplines, approaches, and institutions and empower scientists to pursue breakthroughs at the edge of the possible.